May 9 (Reuters) - Radiopharm Theranostics Ltd (RAD) :
- U.S. FDA GRANTED ORPHAN DRUG DESIGNATION TO GA68-TRIVEHEXIN (RAD 301)
News: RAD Radiopharm Theranostics Says U.S. FDA Granted Orphan Drug Designation To GA68-TRIVEHEXIN
- There are more pages in this discussion • 73 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.81M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.0¢ | 3.0¢ | $4.778K | 159.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3015616 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.1¢ | 355205 | 5 |
View Market Depth
| Last trade - 12.14pm 12/06/2024 (20 minute delay) ? |
| RAD (ASX) Chart |